#EXP00156

General

Accession EXP00156
Activity Preformed biofilm
Date 2013-11-26
Administration In solution
Model in vitro
Organism Pseudomonas aeruginosa
Status Validated
Notes Pa9 clinical isolate

Peptide

SMAP-29

RGLRRLGRKIAHGVKKYGPTVLRIIRIA

Experimental activity

Method Concentration Notes
Total countable CFUs 2.502 uM No notes
Total countable CFUs 12.512 uM No notes

References

Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients

A. Pompilio, M. Scocchi, S. Pomponio, F. Guida, A. Di Primio, E. Fiscarelli, R. Gennaro, G. Di Bonaventura

2011. Peptides 9:1807-1814